Log in to search using one of your social media accounts:

 

National Viral Hepatitis Action Plan 2017-2020 Partner Planning Guide
A tool designed for use by individuals, groups, and organizations that are conducting strategic planning efforts for hepatitis B (HBV) and/or hepatitis C (HCV). (Source: PHPartners.org)
Source: PHPartners.org - February 14, 2018 Category: International Medicine & Public Health Source Type: news

Organ-on-chip technology enters next stage as experts test hepatitis B virus
(Imperial College London) Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2018 Category: International Medicine & Public Health Source Type: news

AAP Releases 2018 Immunization Schedule for Kids and Teens
(MedPage Today) -- New wording for hepatitis B vaccine timing in infants, optional dose of MMR in mumps outbreak (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 6, 2018 Category: American Health Source Type: news

ACIP Issues 2018 Child and Adolescent Vaccine Schedule ACIP Issues 2018 Child and Adolescent Vaccine Schedule
Recommendations clarify who should get a third dose of the mumps vaccine and highlight that the hepatitis B vaccine should be given to all nonpremature babies within the first 24 hours of life.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 6, 2018 Category: Consumer Health News Tags: Pediatrics News Alert Source Type: news

'Virus-cracking' molecules advance fight against hepatitis B
(Indiana University) Indiana University researchers have found that certain molecules -- currently under clinical trial -- are able to 'crack' the protective shell of the hepatitis B virus, suggesting it may be possible to attack the virus after its already taken hold in the body. There is currently no cure for the virus, which can cause liver failure and cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2018 Category: Cancer & Oncology Source Type: news

Aptima(R) HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval
Aptima assay portfolio rapidly expanding with the addition of tests to quantitate HIV-1, HCV and HBV now available on the fully automated Panther system MARLBOROUGH, Mass., Jan. 25, 2018 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (Nasda... Diagnostics, FDA Hologic, Aptima, HBV Quant Assay, Hepatitis B (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2018 Category: Pharmaceuticals Source Type: news

Risks for Hepatitis B Reactivation with Newer Hep C Treatments Detailed
About a quarter of patients with chronic hepatitis B infection experience reactivation of the virus when they receive direct-acting antivirals (DAAs) for hepatitis C... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 22, 2018 Category: Primary Care Source Type: news

With big bucks (and drugs) in hand, George Scangos' startup stakes out space in infectious diseases
Vir Biotechnology is going where Big Pharma has largely backed away — infectious diseases, such as HIV, hepatitis B and tuberculosis — and it's doing so with $600 million in backing from ARCH Venture Partners and others. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 18, 2018 Category: Health Management Authors: Ron Leuty Source Type: news

Panacea Biotec partners Serum Institute for hexavalent vaccine
The vaccine is a combination of six antigens to protect against six dreaded diseases - Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenza type B and Polio. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2018 Category: Pharmaceuticals Source Type: news

Reminding people about vaccinations can increase rates of immunization
Anupdated Cochrane Review, published in the Cochrane Library today, suggests that reminding people when their vaccinations are due or overdue increases the number of people being immunized.Rates of immunization against infectious diseases in children and adults are improving, but under-vaccination remains a problem that results in vaccine-preventable deaths and illnesses. In Europe, 11,316 cases of measles were reported during 2012, and an estimated four to 50 million symptomatic cases of flu occur each year.Reminders can be sent to patients, parents or guardians, or whole populations when vaccines are due, either because ...
Source: Cochrane News and Events - January 15, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

RECOMMENDATIONS AND REPORTS: Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 11, 2018 Category: American Health Source Type: news

Scientists have determined the mummified child who was killed 500 years ago died from hepatitis, not smallpox
(Natural News) Using DNA samples from a 500-year old mummified remains of a child, researchers were able to crack the genetic code of an ancient strain of the hepatitis B virus (HBV). The finding, wherein scientists were able to “sequence the complete genome” of the virus, could help medical experts understand the intricacies of HBV, which is a... (Source: NaturalNews.com)
Source: NaturalNews.com - January 10, 2018 Category: Consumer Health News Source Type: news

Public health-primary care testing has high uptake, doesn't identify hidden hepatitis C
(American Academy of Family Physicians) A strategy to test the general population for hepatitis B and C viruses in areas of high prevalence had high test uptake but did not detect hidden chronic hepatitis C infections. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 9, 2018 Category: International Medicine & Public Health Source Type: news

Trilobites: A Mummified Child ’ s Remains Show Signs of a Modern Scourge
For decades, scientists thought the toddler died nearly 500 years ago from smallpox. New research shows it carried hepatitis B. (Source: NYT Health)
Source: NYT Health - January 5, 2018 Category: Consumer Health News Authors: NICHOLAS ST. FLEUR Tags: Smallpox Mummies and Mummification Hepatitis Italy Source Type: news

DNA analysis of mummified 2-year-old from 16th century shows she died of hepatitis B
An international team of disease detectives has shed new light on a virus that kills almost a million people around the world each year by probing an unusual source — the mummified remains of a young child who died about 450 years ago in Renaissance Italy. (Source: CBC | Health)
Source: CBC | Health - January 4, 2018 Category: Consumer Health News Tags: News/Technology & Science Source Type: news

DNA analysis of mummified 2-year-old from 16th century shows he died of hepatitis B
An international team of disease detectives has shed new light on a virus that kills almost a million people around the world each year by probing an unusual source — the mummified remains of a young child who died about 450 years ago in Renaissance Italy. (Source: CBC | Health)
Source: CBC | Health - January 4, 2018 Category: Consumer Health News Tags: News/Technology & Science Source Type: news

Ancient origin of hepatitis B virus is revealed
Scientists led by McMaster University have sequenced the complete genome of the ancient strain, confirming that the virus has existed in humans for centuries. (Source: the Mail online | Health)
Source: the Mail online | Health - January 4, 2018 Category: Consumer Health News Source Type: news

Boy Who Died 450 Years Ago Gives Clues to Hepatitis Research
THURSDAY, Jan. 4, 2018 -- The mummified remains of an Italian boy who died 450 years ago suggest the hepatitis B virus has infected humans for centuries. The child died in the 16th century. And prior testing suggested smallpox killed him. But a new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 4, 2018 Category: General Medicine Source Type: news

DNA analysis of ancient mummy, thought to have smallpox, points to Hepatitis B instead
(McMaster University) A team of scientists has sequenced the complete genome of an ancient strain of the Hepatitis B virus (HBV), shedding new light on a pervasive, complex and deadly pathogen that today kills nearly one million people every year. While little is known about its evolutionary history and origin, the findings confirm the idea that HBV has existed in humans for centuries. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 4, 2018 Category: Infectious Diseases Source Type: news

Multiple Organ Failure During Telbivudine Treatment for HBV Multiple Organ Failure During Telbivudine Treatment for HBV
While telbivudine is an effective treatment for hepatitis B, this case demonstrates that on rare occasions it can have severe, potentially fatal adverse effects.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 2, 2018 Category: Consumer Health News Tags: Critical Care Journal Article Source Type: news

Hepatitis B Vaccination Rates Subpar in Patients With HIV Hepatitis B Vaccination Rates Subpar in Patients With HIV
More than a third of patients with HIV infection fail to get hepatitis B virus (HBV) vaccination, despite a longstanding recommendation, report researchers from the Centers for Disease Control and Prevention (CDC) in Atlanta.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 28, 2017 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

The prevalence of occupational health-related problems in dentistry: A review of the literature.
CONCLUSION:Occupational health-related problems are still prevalent in current dentistry practice, despite changes in equipment and surgery design. The reported prevalence of occupational related-health problems and other findings of investigative studies highlight the need for continuous professional education and a need to improve clinical practice aspects of dentistry curricula. (Source: Dental Technology Blog)
Source: Dental Technology Blog - December 26, 2017 Category: Dentistry Source Type: news

Pa. Biotech Center leader named to Academy of Inventors
Timothy M. Block, president of the Doylestown-based Hepatitis B Foundation and the Pennsylvania Biotechnology Center of Bucks County, was named a fellow of the U.S. National Academy of Inventors. The status is bestowed on academic inventors who have demonstrated a “prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and welfare of society." Block, who is also president of the foundati on’s… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 22, 2017 Category: Biotechnology Authors: John George Source Type: news

Sudan:Health Ministry - 'Hepatitis B Spreading Rapidly in Khartoum State'
[Radio Dabanga] Khartoum State -Hepatitis B is spreading rapidly in Sudan's Khartoum state, according to a statement by state's Ministry of Health. Sufferers, including both Sudanese and foreigners, are unable to work. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 15, 2017 Category: African Health Source Type: news

Rohingya Refugees: The Woes of Women – Part One
Rohingya women of Balukhali camp embarking on the trek to the toilets. Credit: Umer Aiman Khan/IPSBy Sohara Mehroze ShachiCOX'S BAZAR, Bangladesh, Dec 7 2017 (IPS)Afia* lines up her bucket every morning in the refugee camp for water delivery from humanitarian relief workers. On one particularly sweltering day, she kept four water pitchers in a row with gaps between them, hoping to insert another empty container in the space when the water arrived.When another refugee saw this, she kicked away Afia’s pitchers, and a raging quarrel broke out. That night, the woman’s local boyfriend attacked Afia in her house, kic...
Source: IPS Inter Press Service - Health - December 7, 2017 Category: International Medicine & Public Health Authors: Sohara Mehroze Shachi Tags: Aid Asia-Pacific Development & Aid Featured Gender Violence Headlines Health Human Rights Humanitarian Emergencies IPS UN: Inside the Glasshouse Migration & Refugees Poverty & SDGs Projects Women's Health Bangladesh Internati Source Type: news

ACP, CDC Issue Guidance on Hep B Screening, Treatment
The American College of Physicians and CDC released a clinical guideline on hepatitis B virus infection that offers recommendations on vaccination, screening and linking patients to care. (Source: AAFP News)
Source: AAFP News - November 29, 2017 Category: Primary Care Source Type: news

Uganda:Grains Carry Cancerous Substances, Scientists Warn
[Monitor] Kampala -Makerere University researchers have warned that Ugandans are at risk of contracting liver cancer and hepatitis B after several food crops have been found to contain high levels of fungi-produced toxic chemicals called aflatoxins. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 29, 2017 Category: African Health Source Type: news

HCC in Chronic HBV vs Chronic HCV After Virologic Response HCC in Chronic HBV vs Chronic HCV After Virologic Response
Does the achievement of virologic response modify the risk of hepatocellular carcinoma differently in patients with chronic hepatitis B as compared to those with chronic hepatitis C?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 28, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Elevated Liver Cancer, Death Rates With Chronic HBV Elevated Liver Cancer, Death Rates With Chronic HBV
Patients with immune-tolerant-phase chronic hepatitis B virus (HBV) infection, who are usually not considered for treatment, face an increased risk of hepatocellular carcinoma (HCC) and death, compared with treated immune-active-phase patients, researchers from Korea report.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 22, 2017 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

ACP and CDC issue recommendations for hepatitis B screening, vaccination, and care
(American College of Physicians) Reducing chronic hepatitis B infections by screening at-risk adults, increasing hepatitis B vaccination rates, and linking infected persons to care is a public health priority, the American College of Physicians and the Centers for Disease Control and Prevention advise in a new paper published today in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 20, 2017 Category: Cancer & Oncology Source Type: news

Global Routine Vaccination Coverage, 2016
Global coverage with the third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine, the third dose of polio vaccine, and first dose of measles. Among new or underused vaccines, global coverage increased during 2010-2016 for completed vaccine series against rotavirus (8% to 25%), Streptococcus pneumoniae (11% to 42%), rubella (35% to 47%), Haemophilus influenzae type B (42% to 70%) and hepatitis B vaccine (74% to 84%). containing vaccine coverage has remained unchanged at 84%-86% since 2010. (Source: PHPartners.org)
Source: PHPartners.org - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Heplisav B (Hepatitis B Vaccine Solution for Intramuscular Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 15, 2017 Category: Drugs & Pharmacology Source Type: news

Preventing Perinatal Transmission of Hepatitis B Preventing Perinatal Transmission of Hepatitis B
Dr William Balistreri surveys the latest guidelines and studies aiming to improve maternal and neonatal outcomes.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2017 Category: Consumer Health News Tags: Gastroenterology Expert Column Source Type: news

Health Center Strategies to Advance Prevention of Perinatal Transmission of Hepatitis B Webinar
December 6, 2017 3:00-4:00pm. No registration required. Join on day of session. Call-in: 888-603-9609 Passcode: 8184117 (Source: PHPartners.org)
Source: PHPartners.org - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up
(Reuters) - Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie Gray told Reuters the company was open to, but not waiting for, a partner to market the drug. (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults
BERKELEY, CA -- (Marketwired) -- November 9, 2017 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved Heplisav-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 9, 2017 Category: Drugs & Pharmacology Source Type: news

Promising new drug for Hep B tested at Texas Biomedical Research Institute
(Texas Biomedical Research Institute) Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 7, 2017 Category: Infectious Diseases Source Type: news

Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016
Coverage with most recommended vaccines remained stable and high in 2016; coverage was ≥90% for polio, measles, mumps, and rubella, varicella, and hepatitis B vaccines, and lowest (61%-74%) for hepatitis A, the birth dose of hepatitis B, and rotavirus vaccines, and the combined 7-vaccine series. (Source: PHPartners.org)
Source: PHPartners.org - November 3, 2017 Category: International Medicine & Public Health Source Type: news

National Viral Hepatitis Progress Report
Report highlighting the nation's progress toward reducing the burden of hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infections. (Source: PHPartners.org)
Source: PHPartners.org - November 1, 2017 Category: International Medicine & Public Health Source Type: news

Ahead of Brazil Summit, UN reports 3 million people now have access to hepatitis C cure
A record 3 million people obtained treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016, the United Nations health agency reported Tuesday, the eve of the World Hepatitis Summit in Brazil, highlighting increasing momentum in the global response to the viral disease. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - October 31, 2017 Category: International Medicine & Public Health Source Type: news

Ahead of Brazil Summit, UN reports three million people now have access to hepatitis C cure
A record three million people obtained treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016, the United Nations health agency reported Tuesday, the eve of the World Hepatitis Summit in Brazil, highlighting increasing momentum in the global response to the viral disease. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - October 31, 2017 Category: International Medicine & Public Health Source Type: news

Close to 3 million people access hepatitis C cure
(Source: WHO news)
Source: WHO news - October 31, 2017 Category: International Medicine & Public Health Tags: hepatitis [subject], jaundice, hepatitis a, hepatitis b, hepatitis c, hepatitis e, hepatitis [subject], jaundice, hepatitis a, hepatitis b, hepatitis c, hepatitis e, Press release [doctype] Source Type: news

Mayo Clinic Q and A: Safeguarding the blood supply
DEAR MAYO CLINIC: I have given blood for 25 years, but just recently, I received a letter saying I could not give blood for six months because of an inconclusive hepatitis B test. What does this mean? Will I be able to give blood in the future? ANSWER: The notification you received means the test [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 31, 2017 Category: Databases & Libraries Source Type: news

TAF Bests TDF for Hepatitis B Treatment (CME/CE)
(MedPage Today) -- Less BMD decline with newer drug (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - October 23, 2017 Category: Consumer Health News Source Type: news

Aspirin may reduce risk for liver cancer in hepatitis B patients, study says
Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 20, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Daily aspirin could ward off liver cancer
Taking aspirin every day could help to lower the risk of liver cancer for patients infected with hepatitis B, a new study suggests. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 20, 2017 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?
FRIDAY, Oct. 20, 2017 -- Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 20, 2017 Category: General Medicine Source Type: news

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?
Title: Can Aspirin Stop Liver Cancer in Hepatitis B Patients?Category: Health NewsCreated: 10/20/2017 12:00:00 AMLast Editorial Review: 10/20/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 20, 2017 Category: Nutrition Source Type: news